Microsporidia and Cyclospora: Epidemiology and Assessment of Risk from the Environment.

THE ISSUE

The goal of this paper is to critically analyze the human health risk associat-
ed with waterborne exposure to two relatively newly recognized protozoan
agents: Cyclospora and Microsporidia, so that an approach to developing
appropriate water testing and purification guidelines can be facilitated.

An overview of each of these parasites is presented, along with a discussion of
the health risk that these organisms pose to humans through exposure in our
water supply. The goal is to identify gaps in our current understanding to
assist the development of appropriate and reasonable water quality regula-
tions.

RESEARCH STRATEGY

An analysis of the human health risk associated with waterborne exposure to
Cyclospora and Microsporidia was conducted by Patricia Mota, M.D. and
Stephen Edberg, Ph.D., A.B.M.M. (Yale University School of Medicine).

Cyclospora: History/Life Cycle/Biology

The first reported association of Cyclospora with human disease appeared in
the literature in 1979 in Papua, New Guinea. Previously thought to be blue-
green algae, CLBs (cyanobacterium-like or coccidia-like bodies), or large
species of Cryptosporidium, the observation that these organisms sporulated
and contained typical sporocysts and sporozoites confirmed their coccidian
nature.

In 1986, coccidian-like oocysts 8 to 10 um were identified in the stools of
patients with diarrhea. The organism was identified and named Cyclospora
cayetanensis by Ortega, Oilman, and Sterling.

The entire life cycle of Cyclospora can be completed within human hosts, and
this organism does not replicate outside human hosts. The unsporulated
oocysts are excreted outside the body, and in order to become infectious, the
oocyst must first sporulate in the environment. The excreted oocyte requires 7
to 13 days at 25-32°C to sporulate to two ovoid sporocysts [(each 4x6 (m)j,
each containing two sporozoites.

Cyclospora is an emerging pathogen in the last few years, due in part to sev-
eral well-publicized outbreaks of diarrheal illness that highlight the impact of
a global food market. Among the many gaps in our current understanding are
unknown factors in the life cycle and host susceptibility.

Clinical

Cyclospora infects the small intestine, causing an illness characterized by pro-
longed watery diarrhea, fatigue (sometimes profound), and anorexia in
humans. The incubation period from infection to onset of symptoms averages
one week (Colley 1996). The stools of infected patients are typically watery,
without blood or white blood cells, and may be explosive. Immunity is not
protective, so that re-infection can occur. Cyclospora infects patients of all
ages, both immunocompromised and immunocompetent. Travelers to endem-
ic areas are at an increased risk of infection.

Laboratory Diagnosis

The gold standard for diagnosis of Cyclosporiasis is microscopic identification
of oocysts, which is best performed by a skilled and experienced microscopist.
Cyclospora oocysts can easily be confused with Cryptosporidium parvum,
another coccidian parasite which is often sought as an etiologic agent of diar-
rheal illness.

Epidemiology

Both children and adults are infected with Cyclospora, with higher attack rates
for ages greater than 18 months (Gumbo 1977). The host range for infection
with Cyclospora has not been definitively characterized. The entire life cycle
can be completed in the human intestine. There is apparently a worldwide dis-
tribution, including regions of endemicity, e.g., Nepal, Haiti, and Peru. Thus,
there is increased risk to U.S. citizens through travel to endemic areas.

The oocyst is the environmentally resistant form of the organism which sporu-
lates after 7 to 12 days at ambient temperature. Infections are seasonal, cor-
relating with rainy season (spring/summer) intemperate zones; in the U.S. most
cases have occurred April through August. Intriguing possibilities exist for
link of prevalence of Cyclospora with the Guatemalan "mal de mayo," a spring
diarrheal illness.

About 50 outbreaks have been associated with Guatemalan raspberries in the
last few years, especially during the spring of 1996 and 1997. After the out-
break in 1996, berry growers and exporters in Guatemala voluntarily intro-
duced control measures to improve water quality and sanitary conditions on
farms. The use of the Hazard Analysis and Critical Control Point (HACCP) sys-
tem has been voluntarily introduced in conjunction with the U.S. Food and
Drug Administration and the Centers for Disease Control and Prevention.

Microsporidia: Introduction/Life Cycle/Biology

Microsporidia are ubiquitous spore-forming protozoan parasites of the phylum
Microspora that infect much of the animal kingdom. They first gained noto-
riety as the etiologic agent of disease in silkworms during the last century.

Over 100 genera and almost 1,000 species of microsporidia have been
described (Weber 1994). Taxonomic relationships are based on a combination
of analysis of ultrastructural features and knowledge of the life cycle, as well
as analysis of 16S rRNA genes. Genera associated with human disease
include: Encephalitozoon, Enterocytozoon, Nosema, Pleistophora, Trach-
ipleistophora, Vittaforma, and Microsporidium.

Clinical

After some initial debate about pathogenicity, microsporidia are now widely
accepted as true enteric pathogens, causing disease in the majority of infected
patients. Microsporidiosis is strongly associated with diarrhea in HIV-infect-
ed patients, so that the diarrheal symptoms are not due to immunodeficiency.
Infection with microsporidia is becoming increasingly recognized in HIV
patients. The symptoms of intestinal microsporidiosis are similar to those of
isosporiasis and cryptosporidiosis, although milder. Microsporidiosis is a pro-
tracted, debilitating illness in HIV patients, associated with increased morbid-
ity and mortality (Sobottka 1998).

Laboratory Diagnosis

Microsporidiosis is likely to be under-reported due to inherent difficulties in
diagnosis.

Epidemiology

Although much has been learned of the biology of microsporidia,
relatively little is known compared to what is needed in order to establish
a reasoned and full assessment of the risk to human health.

Because E. bieneusi (one of the species of Micro sporidium) is most likely to be
associated with gastrointestinal illness, transmission is postulated to occur by
the ingestion of spores. Spores are shed in fecal material, so that ingestion
will occur through fecally-contaminated food, water, etc. The small size of the
organisms poses additional challenges for their detection and removal from
water sources. It is important to note that there are many nonpathogenic
species ubiquitous in the environment which may result in false-positive
detection assay results.

MAJOR FINDINGS AND SIGNIFICANCE

A critical review of Aeromonas hydrophila infections, and its potential for reg-
ulation indicates:

  • Cyclospora is primarily a food-associated parasite, is found in surface
    water when the organic content is high, and should not be found in
    subsurface water.
  • Microsporidia primarily affects AIDS patients. It can be transmitted by
    water. It is oxidant sensitive, and of small size.

Mota, P., and Edberg, S.C., Microsporidia and Cyclospora: Epidemiology and Assessment of Risk from the Environment. Critical Reviews in Microbiology. 26(2); 2000.

Order reprints from publisher.